Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-001543-60Phase 2Completed
Phase 2, open-label, single-arm trial of Fibrinogen human in perioperative bleeding, sponsored by University of Gothenburg. Primary endpoint: Adverse events during hospitalization including early graft occlusion. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-001543-60.